More News! For those who want to keep up with everything

meningitis antibiotic resistance lund university

More News! 11 Apr 2019

Scientists Develop Treatment to Combat Antibiotic Resistance in Meningitis

Researchers based in Sweden and Denmark are developing a meningitis treatment that could overcome antibiotic resistance by targeting white blood cells called neutrophils. Antibiotic resistance has become a pressing issue, as many easily treatable infections become harder to fight with traditional antibiotics. Bacterial meningitis is particularly concerning, as its already considerable mortality rate of 10-30% […]

April 11, 2019 - 2 minutesmins - By Jonathan Smith

llama leo pharma argen x skin milestone inflammatory

More News! 3 Apr 2019

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to develop antibody treatments that could regenerate damaged tissue. The round was led by the Belgian investor V-Bio Ventures and Advent France Biotechnology. AgomAb will use the big Series A funding to test antibody treatments for fibrosis in clinical trials, as […]

April 3, 2019 - 2 minutesmins - By Jonathan Smith

synbio genome artificial C eth2.0 bacteria 1

More News! 2 Apr 2019

Swiss Scientists Make Synthetic Bacterial Genome Using Computers

Synthetic biology researchers at ETH Zurich are the first to construct a simplified artificial bacterial genome with the help of computer algorithms, which could lead to better-engineered microorganisms for the production of therapeutics and other chemicals. Back in 2008, US researchers led by the famous biologist John Craig Venter made headlines for synthesizing the genome […]

April 2, 2019 - 3 minutesmins - By Jonathan Smith

bioarctic alzheimers disease plaques amyloid beta neurons Edited

More News! 25 Mar 2019

Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug

The failure of Biogen’s Alzheimer’s disease drug in a phase III trial last week caused BioArctic’s stock price to plummet by 35% on Nasdaq Stockholm. The Swedish company has just begun a phase III trial of its own Alzheimer’s treatment. Last week, Biogen and its pharma collaborator Eisai discontinued the phase III development of an […]

March 25, 2019 - 2 minutesmins - By Jonathan Smith

More News! 4 Mar 2019

Swiss Biotech Raises €8.8M to Progress Regenerative Stroke Treatment

The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop one of the first therapies to help the nervous system regenerate after a stroke. Novago develops antibodies that inhibit Nogo-A, a key molecule that stops nerve cells from growing new connections in the adult brain and spinal cord. This lets […]

March 4, 2019 - 3 minutesmins - By Jonathan Smith

More News! 27 Feb 2019

Carbios Creates First 100% Recycled Plastic Bottles With Enzymes

French biotech Carbios has managed to create plastic bottles from 100% recycled plastic using its specialized enzyme technology. The company’s recycling process focuses on plastic made from polyethylene terephthalate or PET, one of the most commonly used plastics. Importantly, it can be also be used to create customized bottles, a requirement for many brands. Carbios […]

February 27, 2019 - 2 minutesmins - By Helen Albert

arvelle therapeutics SK Biopharmaceuticals Axovant epilepsy

More News! 18 Feb 2019

Enormous Series A to Help Bring Epilepsy Drug to Market

One of the biggest Series A rounds in European biotech, €159M ($180M), has been raised by the Swiss company Arvelle Therapeutics to help commercialize its epilepsy drug. Formed just this month, Arvelle plans to submit an application for EMA approval for the small molecule drug cenobamate, which it has licensed from the South Korean company […]

February 18, 2019 - 2 minutesmins - By Jonathan Smith

london biotech hub medcity british library

More News! 14 Feb 2019

London’s Biotech Ecosystem Boosted with €900M Expansion

The British Library has greenlit the construction of a new research hub on its property in North London, increasing the business potential for the biotech ecosystem in the southeast of England. The new site, costing up to €900M (£800M), will expand premises held by the British Library, which is next to King’s Cross and the […]

February 14, 2019 - 3 minutesmins - By Jonathan Smith

More News! 12 Feb 2019

First Industrial Plant to Turn Waste into Chemicals Will Open in France

The French company Afyren has received up to €60M to commercialize a technology that uses bacteria to produce industrial chemicals from recycled plant waste instead of fossil fuels. Afyren takes sugars from the waste byproducts of agriculture, food, and other industries, and ferments the sugars into industrial chemicals using bacteria. With this new funding, the […]

February 12, 2019 - 2 minutesmins - By Jonathan Smith

More News! 8 Feb 2019

Swiss Firm Launches Cancer Test That Gives Results in Minutes

Lunaphore Technologies has launched a device for automated testing of cancer tissue samples that gives results in under 30 minutes. Lunaphore has developed a piece of next-generation equipment to perform immunohistochemistry (IHC) tests, a common technique used to find specific cancer biomarkers in tissue samples from cancer patients after a biopsy. The equipment, called LabSat, will […]

February 8, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 6 Feb 2019

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

Orexia and Inexia, two new virtual companies spun out of Sosei Heptares, will develop drugs for neurological diseases such as narcolepsy with funding from Medicxi Ventures. The companies will develop drugs that activate two molecules called OX1 and OX2. These molecules act as receptors of orexin, a protein that regulates arousal, wakefulness and sleep. The […]

February 6, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 31 Jan 2019

Watch Strap Made of Recombinant Spider Silk Launches in Europe

Sold by the luxury brand Omega, the watch strap is made with spider silk proteins that are brewed by genetically engineered bacteria. Spider silk is known in the textile industry for its strength, resilience, flexibility and light weight. However, it is not possible to ‘farm’ spiders to produce their silk at an industrial scale. The […]

January 31, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us